PureTech Share News (PRTC)
PRTC Share
PRTC Share
PRTC Share
PRTC Share
PRTC
PRTC Share
PRTC Level 2
PRTC Live
PRTC Broker
PRTC Directors
PRTC Financial
PRTC
PRTC Short
PRTC
Last checked at -
Fri, 04th Feb 2022 14:51
PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Chief Business, Legal & Operating Officer Bharatt Chowrira buys 20,000 shares at GBP2.55, worth GBP51,000, on Thursday.
Current stock price: 261.00 pence, up 2.4% on Friday
12-month change: down 30%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Analysts at Peel Hunt reiterated their 'Conviction Buy' recommendation for shares of PureTech Health following a $110.0m funding round for its founded entity Vor Biopharma, arguing that the transaction validated its business model.
Read moreUK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump
Read more(Sharecast News) - Biotherapeutics company PureTech Health said its founded entity Akili had received a CE-mark for 'EndeavorRx treatment for attention deficit hyperactivity disorder (ADHD).
Read moreIN BRIEF: Puretech Health Partners With China Medical System
Read moreIN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy
Read more(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that its subsidiary Akili has been granted US Food and Drug Administration (FDA) clearance for 'EndeavorRx', or AKL-T01, as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).
Read moreUK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
Read more(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health reported some "positive" topline data from two Phase 1 studies into VE202, its orally-administered inflammatory bowel disease treatment candidate.
Read moreUK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service
Read moreUK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million
Read more(Sharecast News) - Clinical stage biotherapeutics company PureTech Health announced on Tuesday that its founded company Gelesis has received approval to market 'Plenity', a novel weight-loss treatment, in Europe.
Read moreUK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work
Read more(Sharecast News) - PureTech Health announced plans on Thursday to advance its wholly-owned clinical-stage product candidate 'LYT-100', or deupirfenidone, as a potential treatment for serious respiratory complications, including inflammation and fibrosis, that persist following the resolution of Covid-19 infection.
Read moreUK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield
Read more(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics.
Read more
Last checked at